3M (NYSE:MMM) may try to sell off its drug-delivery business in a deal that could fetch $1 billion, according to a report by Bloomberg.
The drug delivery division makes transdermal drug patches, microneedle delivery systems, nasal devices, oral inhalers and packaging films for drug delivery. 3M is also developing a smart inhaler and is looking for pharmaceutical partners for the project.
Get the full story on our sister site, Drug Delivery Business News.